CU Medical Systems Inc (115480) - Net Assets
Based on the latest financial reports, CU Medical Systems Inc (115480) has net assets worth ₩59.68 Billion KRW (≈ $40.44 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩99.66 Billion ≈ $67.54 Million USD) and total liabilities (₩39.99 Billion ≈ $27.10 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 115480 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩59.68 Billion |
| % of Total Assets | 59.88% |
| Annual Growth Rate | 4.1% |
| 5-Year Change | 22.06% |
| 10-Year Change | 43.61% |
| Growth Volatility | 10.41 |
CU Medical Systems Inc - Net Assets Trend (2012–2025)
This chart illustrates how CU Medical Systems Inc's net assets have evolved over time, based on quarterly financial data. See 115480 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for CU Medical Systems Inc (2012–2025)
The table below shows the annual net assets of CU Medical Systems Inc from 2012 to 2025. For live valuation and market cap data, see 115480 stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩59.68 Billion ≈ $40.44 Million |
+1.59% |
| 2024-12-31 | ₩58.74 Billion ≈ $39.81 Million |
+8.34% |
| 2023-12-31 | ₩54.22 Billion ≈ $36.74 Million |
-7.10% |
| 2022-12-31 | ₩58.36 Billion ≈ $39.55 Million |
+19.38% |
| 2021-12-31 | ₩48.89 Billion ≈ $33.13 Million |
+16.80% |
| 2020-12-31 | ₩41.86 Billion ≈ $28.37 Million |
-16.99% |
| 2019-12-31 | ₩50.42 Billion ≈ $34.17 Million |
+6.22% |
| 2018-12-31 | ₩47.47 Billion ≈ $32.17 Million |
+12.82% |
| 2017-12-31 | ₩42.08 Billion ≈ $28.52 Million |
+1.26% |
| 2016-12-31 | ₩41.55 Billion ≈ $28.16 Million |
+9.76% |
| 2015-12-31 | ₩37.86 Billion ≈ $25.66 Million |
+4.73% |
| 2014-12-31 | ₩36.15 Billion ≈ $24.50 Million |
-10.30% |
| 2013-12-31 | ₩40.30 Billion ≈ $27.31 Million |
+13.87% |
| 2012-12-31 | ₩35.39 Billion ≈ $23.98 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to CU Medical Systems Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3390744416000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₩93.58 Billion | 156.82% |
| Total Equity | ₩59.68 Billion | 100.00% |
CU Medical Systems Inc Competitors by Market Cap
The table below lists competitors of CU Medical Systems Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Resverlogix Corp.
TO:RVX
|
$20.64 Million |
|
SE-Education Public Company Limited
BK:SE-ED
|
$20.65 Million |
|
Getabec Public Company Limited
BK:GTB
|
$20.65 Million |
|
Vietnam Sun Corp
VN:VNS
|
$20.65 Million |
|
Yorbeau Resources Inc
TO:YRB
|
$20.63 Million |
|
Pure Hydrogen Corporation Ltd
AU:PH2
|
$20.63 Million |
|
Kyobo 3 SPAC
KQ:208710
|
$20.63 Million |
|
Oxford Instruments PLC
LSE:OXIG
|
$20.62 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CU Medical Systems Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 58,741,589,800 to 59,675,001,180, a change of 933,411,380 (1.6%).
- Net income of 819,203,800 contributed positively to equity growth.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩819.20 Million | +1.37% |
| Other Changes | ₩114.21 Million | +0.19% |
| Total Change | ₩- | 1.59% |
Book Value vs Market Value Analysis
This analysis compares CU Medical Systems Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.94x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.75x to 1.94x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩2556.40 | ₩1916.00 | x |
| 2017-12-31 | ₩2391.82 | ₩1916.00 | x |
| 2018-12-31 | ₩2643.52 | ₩1916.00 | x |
| 2019-12-31 | ₩2429.00 | ₩1916.00 | x |
| 2020-12-31 | ₩1397.73 | ₩1916.00 | x |
| 2021-12-31 | ₩1085.37 | ₩1916.00 | x |
| 2022-12-31 | ₩1279.24 | ₩1916.00 | x |
| 2023-12-31 | ₩1116.78 | ₩1916.00 | x |
| 2024-12-31 | ₩970.54 | ₩1916.00 | x |
| 2025-12-31 | ₩985.96 | ₩1916.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CU Medical Systems Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.37%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.70%
- • Asset Turnover: 0.48x
- • Equity Multiplier: 1.67x
- Recent ROE (1.37%) is above the historical average (-7.57%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 6.16% | 10.07% | 0.48x | 1.27x | ₩-1.36 Billion |
| 2013 | 0.49% | 0.78% | 0.37x | 1.70x | ₩-3.59 Billion |
| 2014 | -10.43% | -14.31% | 0.40x | 1.80x | ₩-6.92 Billion |
| 2015 | 4.44% | 6.55% | 0.38x | 1.76x | ₩-2.10 Billion |
| 2016 | -3.76% | -2.86% | 0.86x | 1.53x | ₩-5.72 Billion |
| 2017 | -7.49% | -5.40% | 0.95x | 1.47x | ₩-7.36 Billion |
| 2018 | 3.69% | 2.29% | 0.73x | 2.21x | ₩-3.00 Billion |
| 2019 | -5.77% | -3.56% | 0.63x | 2.56x | ₩-7.95 Billion |
| 2020 | -61.49% | -90.89% | 0.35x | 1.95x | ₩-29.93 Billion |
| 2021 | -28.60% | -39.49% | 0.49x | 1.49x | ₩-18.87 Billion |
| 2022 | 16.15% | 20.07% | 0.53x | 1.51x | ₩3.59 Billion |
| 2023 | -15.26% | -19.62% | 0.49x | 1.59x | ₩-13.58 Billion |
| 2024 | -5.46% | -7.89% | 0.39x | 1.76x | ₩-9.08 Billion |
| 2025 | 1.37% | 1.70% | 0.48x | 1.67x | ₩-5.15 Billion |
Industry Comparison
This section compares CU Medical Systems Inc's net assets metrics with peer companies in the Healthcare Equipment & Supplies industry.
Industry Context
- Industry: Healthcare Equipment & Supplies
- Average net assets among peers: $92,245,996,289
- Average return on equity (ROE) among peers: 13.26%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CU Medical Systems Inc (115480) | ₩59.68 Billion | 6.16% | 0.67x | $20.63 Million |
| InBody Co.Ltd (041830) | $106.48 Billion | 18.15% | 0.05x | $424.41 Million |
| MEDIANA Co.Ltd (041920) | $56.94 Billion | 11.85% | 0.14x | $78.35 Million |
| Value Added Technology Co. Ltd (043150) | $146.82 Billion | 16.87% | 1.66x | $185.91 Million |
| MEKICS Co Ltd (058110) | $71.00 Billion | 13.35% | 0.36x | $7.52 Million |
| Meta Biomed Co. Ltd (059210) | $44.54 Billion | 4.87% | 1.62x | $60.66 Million |
| INFINITT Healthcare Co. Ltd (071200) | $53.55 Billion | 16.68% | 0.53x | $96.80 Million |
| i-SENS Inc (099190) | $180.93 Billion | 12.50% | 0.39x | $152.30 Million |
| Sewoon Medical Co. Ltd (100700) | $77.72 Billion | 11.81% | 0.11x | $65.72 Million |
About CU Medical Systems Inc
CU Medical Systems, Inc. manufactures and sells defibrillators worldwide. The company offers automatic external defibrillators (AEDs), mechanical cardiopulmonary resuscitation systems, healthcare and rehabilitation products, AED trainers, and sterilizers/disinfectors. It also resells Apple products, including Mac, iPad, and iPod. The company was founded in 2001 and is headquartered in Wonju-si, S… Read more